AstraZeneca | AZN - Umsatzkosten





Umsatzkosten Veränderung Datum
AbbVie USD 4.22B 329M 2026-03
Alcon AG USD 1.18B 26M 2026-03
Almirall EUR 199.26M 7.76M 2026-06
Amgen USD 1.6B 187M 2026-03
argenx SE USD 145M 24M 2026-06
AstraZeneca USD 2.52B 2.73B 2026-06
Autolus Therapeutics Ltd USD 24.57M 762K 2026-03
Bayer EUR 5.23B 731M 2026-03
Biogen USD 797.5M 302M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Eli Lilly USD 3.58B 205M 2026-03
Fresenius EUR 4.45B 262M 2025-12
Fresenius Medical Care EUR 3.43B 248M 2026-03
Genmab DKK 81M 23M 2025-12
Gilead Sciences USD 1.44B 174M 2026-03
GlaxoSmithKline GBP 2.07B 192M 2026-06
GRIFOLS EUR 1.08B 214.82M 2026-03
Haleon GBP 972.5M 258.5M 2025-06
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Lakefront Biotherapeutics EUR 4.8M 4.34M 2026-03
Lonza CHF 2.28B 189M 2025-06
Merck EUR 2.07B 219M 2026-03
Merck USD 2.94B 380M 2026-03
Novartis USD 3.71B 251M 2026-06
Orion EUR 181.7M 18M 2026-06
Pfizer USD 4.59B 1.7B 2026-03
Philips EUR 2.21B 70M 2026-06
Recordati EUR 202.6M 13.03M 2026-03
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 3.67B 621M 2026-03
UCB EUR 1.07B 146M 2025-12